Back to search

Article

Decreased ARID1A Expression Associates with Tumor Progression and Adverse Prognosis in Renal Cell Carcinoma

2021-11-17

Abstract excerpt

In this study, we aimed to evaluate association of ARID1A ( AT-rich interacting domain-containing protein 1A ) mutation and protein expression with clinicopathology and prognosis of renal cell carcinoma (RCC). Genomic Data Commons (GDC) showed ARID1A was one of the top-ten mutated genes found in kidney cancers and its mutations were found along its sequence. Interestingly, patients with ARID1A mutations had signif...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d052752d-6774-5bd6-b819-3c4d71fb238c
DOI
10.21203/rs.3.rs-1034681/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Decreased ARID1A Expression Associates with Tumor Progression and Adverse Prognosis in Renal Cell CarcinomaDOI 10.21203/rs.3.rs-1034681/v1
Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovarySemantic proximity
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis.Semantic proximity
Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinomaSemantic proximity
Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular CarcinomaSemantic proximity
Diagnostic significance and prognostic role of the ARID1A gene in cancer outcomes (Review)Semantic proximity
ARID1 Proteins: from Transcriptional and Post-Translational Regulation to Carcinogenesis and Potential TherapeuticsSemantic proximity
Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian CancersSemantic proximity
ARID1A in cancer: Friend or foe?Semantic proximity
Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular CarcinomaSemantic proximity
Recent advances in the ARID family: focusing on roles in human cancerSemantic proximity
ARID1A mutations in cancer development: mechanism and therapy.Semantic proximity
ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancerSemantic proximity
Select a neighboring publication to make it the new centre.